Dow Down0.62% Nasdaq Down1.14%

More On GLAXF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
23.65 Sep 22, 3:39PM EDT
ProfileGet Profile for:
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
United Kingdom - Map
Phone: 44 20 8047 5000
Website: http://www.gsk.com

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:99,451

Business Summary 

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company’s nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on GlaxoSmithKline plc

Key Executives 
 PayExercised
Sir Andrew Philip Witty , 49
Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
6.09M1.94M
Mr. Simon Dingemans , 50
Chief Financial Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
N/AN/A
Dr. Moncef M. Slaoui Ph.D., 54
Chairman of Global R&D & Vaccines, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
4.17M638.00K
Mr. Daniel E. Troy ,
Sr. VP and Gen. Counsel
N/AN/A
Mr. Philip C. Thomson ,
Sr. VP of Global Communications
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.